(Q48672868)

English

End-capped antisense oligodeoxynucleotides effectively inhibit gene expression in vivo and offer a low-toxicity alternative to fully modified phosphorothioate oligodeoxynucleotides.

scientific article published in July 1997

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/9221920

End-capped antisense oligodeoxynucleotides effectively inhibit gene expression in vivo and offer a low-toxicity alternative to fully modified phosphorothioate oligodeoxynucleotides. (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/9221920

author name string

Hebb MO

1

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/9221920

Robertson HA

2

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/9221920

publication date

1 July 1997

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/9221920

Molecular Brain Research

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/9221920

47

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/9221920

1-2

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/9221920

223-228

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/9221920

Basic local alignment search tool

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2897%2900048-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Oligodeoxynucleoside phosphorothioate stability in subcellular extracts, culture media, sera and cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2897%2900048-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The application of antisense oligonucleotide technology to the brain: some pitfalls

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2897%2900048-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Putative roles for the inducible transcription factor c-fos in the central nervous system: studies with antisense oligonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2897%2900048-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Antisense Therapeutics in the Central Nervous System : The Induction of c-fos

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2897%2900048-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Antisense oligonucleotide eliminates in vivo expression of c-fos in mammalian brain

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2897%2900048-X

7 January 2021

based on heuristic

inferred from DOI database lookup

c-fos antisense reduces expression of Krox 24 in rat caudate and neocortex

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2897%2900048-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Antisense oligodeoxynucleotide inhibition of a swelling-activated cation channel in osteoblast-like osteosarcoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2897%2900048-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Infusion into the brain of an antisense oligonucleotide to the immediate-early gene c-fos suppresses production of fos and produces a behavioral effect

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2897%2900048-X

7 January 2021

based on heuristic

inferred from DOI database lookup

D1-dopamine receptor agonists selectively activate striatal c-fos independent of rotational behaviour

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2897%2900048-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Oligodeoxynucleotides antisense to mRNA encoding protein kinase A, protein kinase C, and beta-adrenergic receptor kinase reveal distinctive cell-type-specific roles in agonist-induced desensitization

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2897%2900048-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Antisense oligonucleotides as therapeutic agents--is the bullet really magical?

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2897%2900048-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Self-stabilized antisense oligodeoxynucleotide phosphorothioates: properties and anti-HIV activity

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2897%2900048-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Antisense oligonucleotides in solution or encapsulated in immunoliposomes inhibit replication of HIV-1 by several different mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2897%2900048-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0169-328X(97)00048-X

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/9221920

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/9221920

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48672868&oldid=1402484211"